Apoptosis
Anti-apoptotic and malignancy-causing protein Mcl-1 inhibited mitochondrial Ca2+ signals
Published in Cancer Weekly, November 15th, 2005
According to recent research from the United States, "Apoptosis contributes to the regulation of cell growth and regeneration and to the development of neoplasia. Mcl-1 is an anti-apoptotic protein that is particularly important for the development of hematological and biliary malignancies, but the mechanism of action of Mcl-1 is unknown."
"A number of pro- and anti-apoptotic proteins exhibit their effects by modulating Ca2+ signals, so we examined the effects of Mcl-1 on components of the Ca2+ signaling pathway that are known to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-11-15)
More Articles from Cancer Weekly
- Cancer Risk Factors
Ovulation stress might cause ovarian cancer - Genetics & Genomics
Increased genomic instability leads to higher cancer incidence in elderly - Genotoxicity
Handling of antineoplastic drugs associated with genotoxic risks in oncology nurses - Tissue Preservation
Novel "tumor banking" method for freezing and storing research tissue specimens described - Adenocarcinomas
Incidence of adenocarcinoma was higher in young patients - Allergy & Immunology
Hepatitis C virus therapy alters the efforts of natural killer T cells - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
